|
C18ORF19 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.299490E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.603300E-03 |
| Normal-vs-Stage2 |
2.603200E-01 |
| Normal-vs-Stage3 |
2.372400E-01 |
| Normal-vs-Stage4 |
5.061800E-01 |
| Stage1-vs-Stage2 |
7.795800E-01 |
| Stage1-vs-Stage3 |
8.217000E-01 |
| Stage1-vs-Stage4 |
7.665600E-01 |
| Stage2-vs-Stage3 |
9.585600E-01 |
| Stage2-vs-Stage4 |
9.455000E-01 |
| Stage3-vs-Stage4 |
9.175800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.478400E-03 |
| Normal-vs-AfricanAmerican |
4.403600E-03 |
| Normal-vs-Asian |
3.434200E-01 |
| Caucasian-vs-AfricanAmerican |
5.534000E-01 |
| Caucasian-vs-Asian |
6.580800E-01 |
| AfricanAmerican-vs-Asian |
7.940400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.316920E-03 |
| Normal-vs-Female |
4.324000E-02 |
| Male-vs-Female |
5.422000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.388000E-02 |
| Normal-vs-Extreme_Weight |
6.32099999999802E-05 |
| Normal-vs-Obese |
4.717900E-02 |
| Normal-vs-Extreme_Obese |
2.634400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.302600E-01 |
| Normal_Weight-vs-Obese |
9.593800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.812200E-02 |
| Extreme_Weight-vs-Obese |
3.034600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.005600E-02 |
| Obese-vs-Extreme_Obese |
3.483900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.181400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.104010E-02 |
| Normal-vs-Age(61-80Yrs) |
8.605000E-03 |
| Normal-vs-Age(81-100Yrs) |
8.368500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.932600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.889600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.736300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.792400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.640500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.650200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.60880000000297E-05 |
| Normal-VS-Type2 PRCC |
5.329800E-01 |
| Normal-VS-KIRP CIMP |
1.207770E-01 |
| Normal-VS-Unclassified PRCC |
4.518000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.503800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.675600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.288000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.355200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.533600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.265000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.336180E-01 |
| Normal-vs-N1 |
1.806360E-01 |
| Normal-vs-N2 |
3.586200E-02 |
| N0-vs-N1 |
7.866000E-01 |
| N0-vs-N2 |
6.335000E-01 |
| N1-vs-N2 |
7.472600E-01 |
|
|
